Wanbury - Quaterly Results

22 Jun 2022 Evaluate
A fair growth of 11.58% in the revenue at Rs. 1343.94 millions was reported in the March 2022 quarter as compared to Rs. 1204.47 millions during year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 825.45 millions grew from Rs.-89.55 millions Operating profit Margin for the quarter ended March 2022 improved to 134.54% as compared to -5.55% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1343.94 1204.47 11.58 5111.86 3925.18 30.23 5111.86 3925.18 30.23
Other Income 6.41 12.12 -47.11 15.08 24.04 -37.27 15.08 24.04 -37.27
PBIDT 134.54 -5.55 -2524.14 368.21 204.24 80.28 368.21 204.24 80.28
Interest 47.89 57.88 -17.26 206.11 230.75 -10.68 206.11 230.75 -10.68
PBDT 850.33 -63.43 -1440.58 925.78 -26.51 -3592.19 925.78 -26.51 -3592.19
Depreciation 30.02 25.87 16.04 114.50 97.54 17.39 114.50 97.54 17.39
PBT 820.31 -89.30 -1018.60 811.28 -124.05 -753.99 811.28 -124.05 -753.99
TAX -5.14 0.25 -2156.00 -3.46 2.00 -273.00 -3.46 2.00 -273.00
Deferred Tax -5.14 -22.43 -77.08 -3.46 -20.68 -83.27 -3.46 -20.68 -83.27
PAT 825.45 -89.55 -1021.78 814.74 -126.05 -746.36 814.74 -126.05 -746.36
Equity 326.66 250.15 30.59 326.66 250.15 30.59 326.66 250.15 30.59
PBIDTM(%) 10.01 -0.46 -2272.50 7.20 5.20 38.43 7.20 5.20 38.43

Wanbury Share Price

253.00 -13.15 (-4.94%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×